When.com Web Search

  1. Ads

    related to: sonidegib fda approval

Search results

  1. Results From The WOW.Com Content Network
  2. Sonidegib - Wikipedia

    en.wikipedia.org/wiki/Sonidegib

    Sonidegib , sold under the brand name Odomzo, is a medication used to treat cancer. [ 1 ] Sonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism).

  3. Hedgehog pathway inhibitor - Wikipedia

    en.wikipedia.org/wiki/Hedgehog_pathway_inhibitor

    Sonidegib has been effective in limiting the invasive potential of multiple cancer types including glioblastoma, [38] prostate cancer, [39] and renal cell carcinoma. [40] It received FDA approval in July 2015 and is being used for the treatment of BCC that has recurred post-surgery or post-radiation therapy.

  4. Hedgehog signaling pathway - Wikipedia

    en.wikipedia.org/wiki/Hedgehog_signaling_pathway

    Several hedgehog signaling pathway inhibitors are available for cancer treatment, such as vismodegib and sonidegib. These drugs are regarded as promising cancer therapies, especially for patients with refractory/advanced cancers. SMO inhibitors represent a potential treatment for some types of cancers.

  5. FDA approves opioid-free pain medication with 'no sign of ...

    www.aol.com/fda-approves-opioid-free-pain...

    A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

  6. Vertex Pharma Just Scored a Major FDA Approval. Is the ... - AOL

    www.aol.com/vertex-pharma-just-scored-major...

    The U.S. Food and Drug Administration (FDA) approved the drug for use in acute pain, but Vertex aims to eventually win approval in chronic pain, too. Clinical trials are ongoing, ...

  7. Philip A. Beachy - Wikipedia

    en.wikipedia.org/wiki/Philip_A._Beachy

    Publications and patents from Beachy’s laboratory have now led to the FDA approval of three Hedgehog pathway inhibitors (vismodegib, sonidegib, and glasdegib, all cyclopamine mimics) that have been approved by the FDA as therapeutics for advanced basal cell carcinoma and acute myelogenous leukemia, with therapeutic use for additional Hedgehog ...

  8. Red Dye 3 Just Got Banned. These Are the Foods to Avoid If ...

    www.aol.com/lifestyle/red-dye-3-just-got...

    At the time of the 1990 decision, the FDA stated it "decided not to take action at that time, given the resources required to remove this authorization," as Red Dye No. 3 had already been approved ...

  9. Vismodegib - Wikipedia

    en.wikipedia.org/wiki/Vismodegib

    Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). [3] The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. [4]

  1. Ads

    related to: sonidegib fda approval